A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients

20Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Background: A single nucleotide polymorphism (SNP) in the epidermal growth factor (EGF) gene (rs4444903) has been associated with increased risk of cancer, including hepatocellular carcinoma (HCC). The aim of this study was to examine the relationship between the EGF SNP genotype and the development and prognosis of HCC, in a Japanese population. Methods: Restriction fragment-length polymorphism was used to determine the presence of the EGF SNP genotype in 498 patients, including 208 patients with HCC. The level of EGF messenger ribonucleic acid (mRNA) expression in cancerous tissues was measured by quantitative reverse transcription polymerase chain reaction. The correlation between the EGF SNP genotype and prognosis was statistically analyzed in the patients with HCC. Results: The proportion of the A/A, A/G, and G/G genotypes were 5.3%, 42.8%, and 51.9%, respectively, in the patients with HCC, whereas in those without HCC, they were 8.6%, 35.9%, and 55.5%, respectively, revealing that the odds ratio (OR) of developing HCC was higher in patients with a G allele (OR =1.94, P=0.080 for A/G patients and OR =1.52, P=0.261 for G/G patients, as compared with A/A patients). In particular, when the analysis was limited to the 363 patients with hepatitis C, the OR for developing HCC was 3.54 (P=0.014) for A/G patients and was 2.85 (P=0.042) for G/G patients, as compared with A/A patients. Tumoral EGF mRNA expression in G/G patients was significantly higher than that in A/A patients (P=0.033). No statistically significant differences were observed between the EGF SNP genotype and disease-free or overall survival. Conclusion: The EGF SNP genotype might be associated with a risk for the development of HCC in Japanese patients but not with prognosis. Of note, the association is significantly stronger in patients with hepatitis C, which is the main risk factor for HCC in Japan. © 2013 Suenaga et al.

References Powered by Scopus

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

14296Citations
N/AReaders
Get full text

Gene expression in fixed tissues and outcome in hepatocellular carcinoma

1108Citations
N/AReaders
Get full text

Molecular targeted therapies in hepatocellular carcinoma

934Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Update in global trends and aetiology of hepatocellular carcinoma

268Citations
N/AReaders
Get full text

Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl<inf>4</inf>-induced hepatotoxicity in rats

77Citations
N/AReaders
Get full text

Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: A meta-analysis based on 16 studies

25Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Suenaga, M., Yamada, S., Fujii, T., Fuchs, B. C., Okumura, N., Kanda, M., … Kodera, Y. (2013). A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients. OncoTargets and Therapy, 6, 1805–1812. https://doi.org/10.2147/OTT.S53625

Readers over time

‘14‘16‘17‘18‘19‘20‘21‘2500.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Professor / Associate Prof. 3

33%

Researcher 2

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

56%

Nursing and Health Professions 2

22%

Mathematics 1

11%

Biochemistry, Genetics and Molecular Bi... 1

11%

Save time finding and organizing research with Mendeley

Sign up for free
0